The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us?

OBJECTIVE: There is limited and conflicting evidence on the association between proton pump inhibitors (PPIs) and myocardial infarction (MI). This study aims to examine the occurrence of MI associated with PPI use from the Food and Drug Administration (FDA) Adverse Event Reporting System database. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jiun Ming, Parsons, Richard, Sim, Tin Fei, Lee, Ya Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830015/
https://www.ncbi.nlm.nih.gov/pubmed/31728342
http://dx.doi.org/10.4103/jrpp.JRPP_19_73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830015/
https://www.ncbi.nlm.nih.gov/pubmed/31728342
http://dx.doi.org/10.4103/jrpp.JRPP_19_73

Ejemplares similares